H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel
Phase 4
Completed
- Conditions
- Coronary Artery DiseaseElective Percutaneous Coronary Intervention
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2012-08-21
- Lead Sponsor
- Hopital du Sacre-Coeur de Montreal
- Target Recruit Count
- 120
- Registration Number
- NCT00433784
- Locations
- 🇨🇦
Hôpital du Sacré-Coeur de Montréal, Montréal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath